Case Report: Cardiotoxic Syncope and Sudden Cardiac Death Due to Carboplatin Use
DOI:
https://doi.org/10.5281/zenodo.17038161Keywords:
Cardiotoxic Syncope, Sudden Cardiac Death, CarboplatinAbstract
With the prolongation of life, the use of multiple drugs occurs especially in elderly patients. Drugs used by geriatric patients and individuals with comorbid diseases may cause changes at the cell level that will cause mortal and morbid effects. Heart failure and cardiac syncope caused by the effect of cardiotoxic drugs are important risk factors for sudden cardiac death as stated in the literature. In our case, sudden cardiac death after cardiac syncope of a patient with metastatic breast cancer using carboplatin was presented.
References
1. Thijs, R.D., et al., Unconscious confusion--a literature search for definitions of syncope and related disorders. Clin Auton Res, 2005. 15(1): p. 35-9.
2. Quinn, J.V., et al., Derivation of the San Francisco Syncope Rule to predict patients with short-term serious outcomes. Ann Emerg Med, 2004. 43(2): p. 224-32.
3. Sun, B.C., et al., External validation of the San Francisco Syncope Rule. Ann Emerg Med, 2007. 49(4): p. 420-7, 427 e1-4.
4. Squibb, B.-M., Paraplatin (carboplatin aqueous solution) injection prescribing information. 2004, NJ: Princeton.
5. Oun, R., Y.E. Moussa, and N.J. Wheate, The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans, 2018. 47(19): p. 6645-6653.
6. Krahn, A.D., J.G. Andrade, and M.W. Deyell, Selecting appropriate diagnostic tools for evaluating the patient with syncope/collapse. Prog Cardiovasc Dis, 2013. 55(4): p. 402-9.
7. Soteriades, E.S., et al., Incidence and prognosis of syncope. N Engl J Med, 2002. 347(12): p. 878-85.
8. Gore, M., et al., Randomized trial of dose-intensity with single-agent carboplatin in patients with epithelial ovarian cancer. London Gynaecological Oncology Group. J Clin Oncol, 1998. 16(7): p. 2426-34.
9. Cheng, C.F., et al., Pravastatin attenuates carboplatin-induced cardiotoxicity via inhibition of oxidative stress associated apoptosis. Apoptosis, 2008. 13(7): p. 883-94.
10. Sakai, T., et al., [A case report of cardiac failure caused by the new anti-neoplastic agent 'carboplatin']. Masui, 1993. 42(5): p. 756-60.
11. Fukuhara, H., et al., Long-term administration of single-agent carboplatin (AUC 4) for advanced testicular seminoma safely achieved complete response in an 80-year-old man with chronic heart failure: A case report. Can Urol Assoc J, 2014. 8(11-12): p. E931-3.
12. Koene, R.J., W.O. Adkisson, and D.G. Benditt, Syncope and the risk of sudden cardiac death: Evaluation, management, and prevention. J Arrhythm, 2017. 33(6): p. 533-544.
13. Liberthson, R.R., Sudden death from cardiac causes in children and young adults. N Engl J Med, 1996. 334(16): p. 1039-44.
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ayşe Şeyma Durkaya
This work is licensed under a Creative Commons Attribution 4.0 International License.
